Funding and Investments

Absci and Caltech Collaborate to Accelerate Affordable HIV Therapeutic Vaccine

August 17, 2023

A major grant from the Bill & Melinda Gates Foundation will bolster efforts to fight the global HIV/AIDS epidemic.

Biovian Invests €50 Million in Manufacturing Facility in Finland

July 28, 2023

The expansion project is aimed to be completed in December 2024 and the new facility will be fully operational by 2025.

MilliporeSigma Expands Production Facility for Cell Culture Media

July 27, 2023

MilliporeSigma has invested $25 million to expand its cell culture media production facility in Lenexa, Kan.

Crossbow Therapeutics Debuts with $80 Million in Series A Financing to Advance Antibody Therapeutics

July 24, 2023

Newly launched Crossbow Therapeutics will work to advance a novel class of antibody therapies for treating cancers.

metabion Expands Oligonucleotide Production Capacity in Germany

July 14, 2023

German manufacturer metabion is conducting a multi-million euro expansion of its oligonucleotide manufacturing capacity in Munich East.

Saudi Arabia’ PIF Launches Lifera, a New CDMO

June 21, 2023

PIF has established Lifera, a new manufacturing entity that will manufacture, stockpile, and supply bio/pharmaceuticals both locally and through partnerships.

Enzene Biosciences Invests $50 Million into New Jersey Biomanufacturing Facility

June 21, 2023

India’s Enzene Biosciences is investing $50 Million into a new biopharma manufacturing plant in Hopewell, NJ.

MilliporeSigma Invests €35 Million to Strengthen Biosafety Testing in Scotland

June 07, 2023

Under the €35 million (US$37 million) investment, MilliporeSigma will expand its sites in Glasgow and Stirling, Scotland, to increase biosafety testing for drug development and commercialization.

invoX Pharma Invests in pHion Therapeutics to Develop Next-Generation mRNA Vaccines

June 06, 2023

invoX Pharma has made a second tranche of investment in pHion Therapeutics to support further development of next-generation mRNA vaccines.

WuXi Biologics Expands Manufacturing Capacity in Germany

June 01, 2023

WuXi Biologics is expanding its manufacturing capacity for drug substance and drug product at its sites in Leverkusen and Wuppertal, Germany.